首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Bioorganic & medicinal chemistry

缩写:BIOORGAN MED CHEM

ISSN:0968-0896

e-ISSN:1464-3391

IF/分区:3.5/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引11389
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Hao Zhang,Tianlong Lan,Rui Li et al. Hao Zhang et al.
The C797S mutation in the epidermal growth factor receptor (EGFR) presents a significant challenge in treating non-small cell lung cancer (NSCLC), as it confers resistance to osimertinib. To tackle this issue, we designed and synthesized no...
Hang Wang,Tong Ji,Jingjing Liu et al. Hang Wang et al.
Protein-protein interaction (PPI) with cochaperones could induce conformational changes of Hsp70. The Hsp70/BAG3 PPI shows tumor specificity and could be regarded as potential targets for cancer therapy. In this paper, a de novo structure-b...
Inès Jacquet,Caroline Castera-Ducros,Romain Paoli-Lombardo et al. Inès Jacquet et al.
To explore the antileishmanial structure-activity relationships in a 3-nitroimidazo[1,2-a]pyridine series, we developed a previously undescribed olefination strategy at position 2 via elimination of intermediates bearing an N-tosyl group, g...
Tengxiao Sun,Wei Zheng,Haiguo Sun et al. Tengxiao Sun et al.
Orthopoxviruses, particularly the monkeypox virus, can cause acute systemic disease accompanied by excessive inflammatory immune responses, while therapeutic options remain limited. In this study, a series of tricyclononene derivatives were...
Xin Ma,Siqi Li,Xinyue Huang et al. Xin Ma et al.
Histone deacetylase inhibitors (HDACis) are a class of epigenetic drugs that, as the name suggests, inhibit histone deacetylases (HDACs), which are anticancer therapeutic targets. Several studies have investigated hydroxamic acid HDACi. How...
Xizheng Quan,Yumei Chen,Fangli Ma et al. Xizheng Quan et al.
Histone deacetylases (HDACs) have been identified as a class of crucial epigenetic enzymes that are responsible for the removal of acetyl groups from the lysine residues in the amino-terminal tails of histones. Their overexpression is close...
Xiaoling Cheng,Weiji Chen,Wenli Hao et al. Xiaoling Cheng et al.
Triple-negative breast cancer (TNBC) remains a challenging malignancy due to its aggressive nature and lack of targeted therapies. Miliusol, a natural product isolated from Miliusa tenuistipitata, exhibits potent anti-proliferative activity...
Mengwei Song,Ying Zhou,Sen Wang et al. Mengwei Song et al.
Breast cancer is the most prevalent malignant tumor among women worldwide, and recurrence, metastasis, and drug resistance remain major challenges that compromise treatment efficacy and patient prognosis. Piperine has been reported to posse...
Jung Hwan Choi,Hyun-Ha Hwang,Jinwon Hong et al. Jung Hwan Choi et al.
Butein, a naturally occurring chalcone, exhibits diverse pharmacological potential but suffers from limited anticancer efficacy. To address this limitation and improve drug-likeness, we designed and synthesized a novel series of 3-deoxy-4-s...
Akash Panja,Pousali Mitra,Iryna Tkachenko et al. Akash Panja et al.
Peptide-drug conjugates (PDCs) represent a targeted cancer therapy strategy that combines tumor-homing peptides with potent cytotoxic payloads, offering a promising alternative to antibody-drug conjugates (ADCs) through improved tissue pene...